Vascular biology

jeremiah JCI-resize570x923-resize550x890.jpg

DLL4 promotes continuous lacteal regeneration in the adult small intestine.

(A) During normal homeostasis the intestinal villi are subject to many stressors, including dietary fat, the gut microbiota, and villus movements, which lacteals encounter as chylomicrons, TLR ligands, and mechanical stress, respectively. In normal mice, VEGFC/D signaling, through VEGFR2 and VEGFR3, promotes lacteal DLL4 expression and Notch signaling, thus maintaining LEC survival, sprouting, and migration to replace damaged cells. Furthermore, LECs in lacteals have both continuous and discontinuous adherens junctions, balancing the need for continuous regeneration with the need for efficient chylomicron uptake. (B) In the absence of DLL4, lacteals are unable to undergo remodeling and have impaired survival and migration and thus are not able to maintain the normal length in villi. Lymphatic Dll4 deletion also promotes a shift from mixed adherens junctions to mostly continuous junctions, contributing to inefficient chylomicron uptake and transport. MLN, mesenteric lymph node.

Bernier-Latmani J., JCI, 2015

Foxc2 abstract-resize570x490.jpg


FOXC2 and fluid shear stress stabilize postnatal lymphatic vasculature by enhancing cell-cell junction integrity and inducing cell-cycle arrest.

Collecting lymphatic vessels contain a large number of lymphatic valves, characterized by areas of persistent disturbed flow in valve sinuses. Disturbed flow (modeled by OSS) induces expression of FOXC2, formation of overlapping intercellular junctions, and nuclear accumulation of TAZ. FOXC2 protects integrity of the overlapping cell-cell junctions and the cortically organized actin cytoskeleton and prevents the proliferative action of TAZ. In the absence of FOXC2, OSS potentiates the cell-cell junction defects, activates cytoskeleton remodeling, and induces TAZ-dependent cell proliferation and death.
Sabine A., JCI, 2015

Chemin des Boveresses 155 - CH-1066 Epalinges
Tel. +41 21 692 58 42
Fax +41 21 652 69 33
Centre Hospitalier Universitaire Vaudois (CHUV)Swiss Institute for Experimental Cancer Research (ISREC)Université de LausanneLudwig Cancer Research